Zorblisa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zorblisa, covering 2019-08-02 to 2019-08-02. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa [Phase 3]